Scalper1 News
Top-rated drugmakers such as Valeant Pharmaceuticals International (VRX) and Celgene (CELG) have been busy in the lab and on Wall Street, taking part in big merger deals. Today’s IBD 50 list features five top-rated drugmakers. In addition to Valeant and Celgene, the list includes Regeneron Pharmaceuticals (REGN), Lannett (LCI) and Allergan (AGN). On Friday Biogen Idec (BIIB) priced $6 billion of senior notes, a day after Gilead Sciences (GILD) Scalper1 News
Scalper1 News